ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовости
Деривативы
TraderScreen

VERBUND AG INH. A/  AT0000746409  /

Düsseldorf
14.06.2024  9:30:27 Изменение +0.40 Объем сделки Бид11:33:25 Предложение11:33:25 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
75.70EUR +0.53% 0
Оборот: 0.00		 75.35Величина цены спроса: 240 75.75Величина цены предложения: 240 26.23 млрдEUR 5.50% 11.58
TeleTrader 11:34 Putin: World has come close to point of no return
Newsfile Corp 11:31 NETA Auto Announces Over 30,000 Orders Within 35 Days Since Launch
Newsfile Corp 11:30 Research from Hellotickets Reveals the Best and Worst Travel Destinations in Europe for Hayfever Suf...
Newsfile Corp 11:23 BabyBonk (BABYBONK) Is Now Available for Tranding on LBank Exchange
TeleTrader 11:05 Fitch: Tariffs on Chinese EVs may affect German automakers
TeleTrader 11:00 Eurozone's trade surplus at €15 billion in April
GlobeNewswire 11:00 Study: Texas Housing Markets Moderating Among Sunbelt States
TeleTrader 10:55 French far-right Le Pen promises 'unity gov't' if party wins
Newsfile Corp 10:54 Speech and More Launches Comprehensive Speech Therapy Services Across Australia
TeleTrader 10:39 Tesla China recalling 5,836 vehicles
TeleTrader 10:37 China protests Turkey's 40% tariff on imported cars
TeleTrader 10:24 Wall Street mostly lower premarket after economic data
TeleTrader 9:51 Russia slams US-Ukraine 10-year security deal
TeleTrader 9:26 BoJ's Ueda: July rate hike possible based on data
GlobeNewswire 9:15 HSBC Bank plc: Post Stabilisation Notice
GlobeNewswire 9:11 Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire 9:05 Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings Report
GlobeNewswire 9:02 Flash News: OKX Announces Exclusive Minting of Slerf NFTs on its Marketplace
TeleTrader 9:02 European markets mixed at open amid data releases
GlobeNewswire 9:01 Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire 9:00 Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire 9:00 Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire 9:00 Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
TeleTrader 8:47 French inflation rises from 2.2% to 2.3% in May
TeleTrader 8:25 Israeli forces destroy explosives stockpile in Rafah